Abstract
Coronavirus disease 2019 (COVID-19) is associated to neuromuscular symptoms in up to 10.7% of hospitalized patients. The prevalence and the characteristics of intensive care unit acquired weakness (ICUAW) in patients affected by COVID-19 have been extensively assessed, although no distinctive pattern was found. ICUAW has been described as a potential confounding factor during the identification of severe acute respiratory syndrome coronavirus 1-related myopathy. In order not to incur this potential bias, we focused on a subset of non-severe cases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
